Management Change30 Jun 2026, 06:00 pm
Emcure Pharmaceuticals: API Business Head to Retire June 2026
AI Summary
Emcure Pharmaceuticals Ltd has announced that Mr. Kuber Jagdale, President of its API Business, will superannuate from his employment on June 30, 2026. Consequently, he will cease to be a Senior Management Personnel of the company. This departure is due to retirement and not a resignation. The company has provided the necessary disclosures as per SEBI Listing Regulations. Mr. Jagdale's tenure marks the end of an era for the API business leadership.
Key Highlights
- API Business President Kuber Jagdale to retire on June 30, 2026.
- Cessation is due to superannuation, not resignation.
- Mr. Jagdale will no longer be considered Senior Management Personnel.
- Disclosure made as per SEBI Listing Regulations.
Price Impact
More from EMCURE